Cargando…

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis

Detalles Bibliográficos
Autores principales:	Sassano-Higgins, Sean A., Pato, Michele T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319248/ https://www.ncbi.nlm.nih.gov/pubmed/25709352 http://dx.doi.org/10.4103/0976-500X.149144

Ejemplares similares

CLOMIPRAMINE IN RESISTANT OBSESSIVE COMPULSIVE DISORDER
por: Khanna, Sumant, et al.
Publicado: (1988)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Shahini, Najmeh, et al.
Publicado: (2021)

Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder
por: Seo, Eun Hyun, et al.
Publicado: (2023)

Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
por: Arrojo-Romero, Manuel, et al.
Publicado: (2013)

Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
por: Karameh, Wael Karameh, et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
por: Vakili, Yaghoob, et al.
Publicado: (2015)

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Nikzad, Faezeh, et al.
Publicado: (2021)

Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients
por: Dadashi, Mohsen, et al.
Publicado: (2020)

Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2016)

OBSESSIVE COMPULSIVE NEUROSIS : CLOMIPRAMINE, PROLACTIN AND THERAPEUTIC RESPONSE
por: Ananth, Jambur, et al.
Publicado: (1997)

Cognitive Function before and during Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Depression or Obsessive-Compulsive Disorder
por: Sayyah, Mehdi, et al.
Publicado: (2016)

Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study
por: Chu, Che-Sheng, et al.
Publicado: (2016)

The effects of selective serotonin reuptake inhibitors on brain functional networks during goal-directed planning in obsessive–compulsive disorder
por: Kim, Minah, et al.
Publicado: (2020)

Adjunctive therapeutic strategies in Obsessive-Compulsive Disorder resistant to serotonin reuptake inhibitors: a literature review
por: Regueira, P., et al.
Publicado: (2022)

The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
por: Kotapati, Vijaya Padma, et al.
Publicado: (2019)

In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder
por: Ghumman, Shazia Akram, et al.
Publicado: (2023)

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
por: Dold, Markus, et al.
Publicado: (2015)

Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
por: Fornaro, Michele
Publicado: (2011)

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder
por: Fineberg, Naomi A., et al.
Publicado: (2018)

Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
por: Xu, Jiao, et al.
Publicado: (2021)

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

Efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management: A treatment comparison
por: Samantaray, Narendra Nath, et al.
Publicado: (2018)

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder
por: Zhang, Kai, et al.
Publicado: (2019)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial
por: Humble, Mats B., et al.
Publicado: (2016)

Serotonin transporter gene polymorphisms & obsessive-compulsive disorder
por: Nicolini, Humberto
Publicado: (2010)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
por: Thamby, Abel, et al.
Publicado: (2019)

Glutamatergic augmentation strategies in obsessive–compulsive disorder
por: Sheshachala, Karthik, et al.
Publicado: (2019)

SUCCESSFUL TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER WITH ZIMELIDINE, A SEROTONIN RE-UPTAKE INHIBITOR
por: Prasad, Ashoka
Publicado: (1983)

Mirtazapine Augmentation for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Retropective Investigation
por: Atmaca, Murad, et al.
Publicado: (2011)

Serotonin Syndrome after Clomipramine Overdose in a Child
por: Direk, Meltem Çobanoğulları, et al.
Publicado: (2016)

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
por: Eissazade, Negin, et al.
Publicado: (2023)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b3q7k6s3ug37e08e8g72k33ce0